Redmile Group, LLC
Q1 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
56
- Value ($000)
$1,057,998
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001425738
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SRRK SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $141.40M | 13 % | 4,398,281 | ||
KRYS KRYSTAL BIOTECH INC | COM | 501147102 | $133.00M | 13 % | 737,675 | ||
FOLD AMICUS THERAPEUTICS INC | COM | 03152W109 | $77.79M | 7 % | 9,533,669 | ||
ZYME ZYMEWORKS INC | COM | 98985Y108 | $57.04M | 5 % | 4,788,945 | ||
NRIX NURIX THERAPEUTICS INC | COM | 67080M103 | $48.14M | 5 % | 4,051,927 | ||
REPL REPLIMUNE GROUP INC | COM | 76029N106 | $47.76M | 5 % | 4,898,527 | ||
LIVANOVA PLC | SHS | G5509L101 | $39.84M | 4 % | 1,014,139 | ||
AKRO AKERO THERAPEUTICS INC | COM | 00973Y108 | $38.02M | 4 % | 939,277 | ||
IMNM IMMUNOME INC | COM | 45257U108 | $36.08M | 3 % | 5,361,187 | ||
RGNX REGENXBIO INC | COM | 75901B107 | $34.28M | 3 % | 4,794,780 |
Rows Per Page
10
- 10
- 50
- 100